Restoration of acetylcholinesterase activity by Euphorbia hirta in discrete brain regions of chronically stressed rats

Pharmaceutical Biology

Volumn 48, Issue 5, 2010, Pages 499-503

  Anuradha, H ^a   Srikumar, B N ^b,c   Deepti, N ^b   Shankaranarayana Rao, B S ^b   Lakshmana, M ^a  

^a Government College of Pharmacy   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^c University of Bordeaux   (France)

Author keywords

Acetylcholinesterase activity; Anxiety; Cholinergic transmission; Chronic stress; Euphorbia hirta; Herbal drugs

Indexed keywords

ACETYLCHOLINESTERASE; ANXIOLYTIC AGENT; EUPHORBIA HIRTA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CHOLINERGIC SYSTEM; CHRONIC STRESS; DRUG EFFICACY; ENZYME ACTIVITY; EUPHORBIA; EUPHORBIA HIRTA; FORCED SWIMMING TEST; FRONTAL CORTEX; HIPPOCAMPUS; IMMOBILIZATION STRESS; MALE; NONHUMAN; RAT; SEPTUM PELLUCIDUM; TRANQUILIZING ACTIVITY; TREATMENT DURATION;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; CHRONIC DISEASE; ENZYME ACTIVATION; EUPHORBIA; MALE; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL;

CHAMAESYCE HIRTA; EUPHORBIACEAE; RATTUS;

EID: 77951846229     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880200903188534     Document Type: Article

References (34)

1. Aguirre-Hernandez E, Rosas-Acevedo H, Soto-Hernandez M, Martinez AL, Moreno J, Gonzalez-Trujano ME (2007): Bioactivity-guided isolation of beta-sitosterol and some fatty acids as active compounds in the anxiolytic and sedative effects of Tilia americana var. mexicana. Planta Med 73:1148-1155.
2. A receptor benzodiazepine receptor-Cl-channel complex. J Neural Transm 115:35-42.
3. Barros M, Giorgetti M, Souto AA, Vilela G, Santos K, Boas NV, Tomaz C (2007): Persistent anxiety-like behavior in marmosets following a recent predatory stress condition: reversal by diazepam. Pharmacol Biochem Behav 86:705-711.
4. Bodnoff SR, Humphreys AG, Lehman JC, Diamond DM, Rose GM, Meaney MJ (1995): Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J Neurosci 15:61-69.
5. Brioni JD, O'Neill AB, Kim DJ, Decker MW (1993): Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plusmaze test. Eur J Pharmacol 238:1-8.
6. Brown E, Hurd NS, McCall S, Ceremuga TE (2007): Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. AANA J 75:333-337.
7. Carlini EA (2003): Plants and the central nervous system. Pharmacol Biochem Behav 75:501-512.
8. Degroot A, Wade M, Salhoff C, Davis RJ, Tzavara ET, Nomikos GG (2004): Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: Reversal by chlordiazepoxide. Eur J Pharmacol 493:103-109.
9. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961): A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95.
10. File SE, Kenny PJ, Cheeta S (2000): The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav 66:65-72.
11. Gold PE (2003): Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Mem 80:194-210.
12. Govindarajan A, Shankaranarayana Rao BS, Nair D, Trinh M, Mawjee N, Tonegawa S, Chattarji S (2006): Transgenic brainderived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci USA 103:13208-13213.
13. Kennedy DO, Pace S, Haskell C, Okello EJ, Milne A, Scholey AB (2006): Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery. Neuropsychopharmacology 31:845-852.
14. Kienzle-Horn S (2002): Herbal medicines for neurological diseases. Curr Opin Investig Drugs 3:763-767.
15. Lamprea MR, Cardenas FP, Silveira R, Walsh TJ, Morato S (2003): Effects of septal cholinergic lesion on rat exploratory behavior in an open-field. Braz J Med Biol Res 36:233-238.
16. Lewis PR, Shute CC, Silver A (1967): Confirmation from choline acetylase analyses of a massive cholinergic innervation to the rat hippocampus. J Physiol 191:215-224.
17. Magarinos AM, McEwen BS (1995): Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 69:89-98.
18. McEwen BS (2000): The neurobiology of stress: From serendipity to clinical relevance. Brain Res 886:172-189.
19. McLay RN, Freeman SM, Zadina JE (1998): Chronic corticosterone impairs memory performance in the Barnes maze. Physiol Behav 63:933-937.
20. McNaughton N, Gray JA (2000): Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. J Affect Disord 61:161-176.
21. Mellgren SI, Srebro B (1973): Changes in acetylcholinesterase and distribution of degenerating fibres in the hippocampal region after septal lesions in the rat. Brain Res 52:19-36.
22. Pung T, Klein B, Blodgett D, Jortner B, Ehrich M (2006): Examination of concurrent exposure to repeated stress and chlorpyrifos on cholinergic, glutamatergic, and monoamine neurotransmitter systems in rat forebrain regions. Int J Toxicol 25:65-80.
23. Rajarao SJ, Platt B, Sukoff SJ, Lin Q, Bender CN, Nieuwenhuijsen BW, Ring RH, Schechter LE, Rosenzweig-Lipson S, Beyer CE (2007): Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon. Neuropeptides 41:307-320.
24. Ramkumar K, Srikumar BN, Shankaranarayana Rao BS, Raju TR (2008): Self-stimulation rewarding experience restores stressinduced CA3 dendritic atrophy, spatial memory deficits and alterations in the levels of neurotransmitters in the hippocampus. Neurochem Res 33:1651-1662.
25. Roche M, Commons KG, Peoples A, Valentino RJ (2003): Circuitry underlying regulation of the serotonergic system by swim stress. J Neurosci 23:970-977.
26. Rodgers RJ, Cole JC (1995): Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety. Behav Pharmacol 6:283-289.
27. Saeed SA, Bloch RM, Antonacci DJ (2007): Herbal and dietary supplements for treatment of anxiety disorders. Am Fam Physician 76:549-556.
28. Sienkiewicz-Jarosz H, Czlonkowska AI, Siemiatkowski M, Maciejak P, Szyndler J, Plaznik A (2000): The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia. J Neural Transm 107:1403-1412.
29. Srikumar BN, Raju TR, Shankaranarayana Rao BS (2006): The involvement of cholinergic and noradrenergic systems in behavioral recovery following oxotremorine treatment to chronically stressed rats. Neuroscience 143:679-688.
30. Srikumar BN, Raju TR, Shankaranarayana Rao BS (2007): Contrasting effects of bromocriptine on learning of a partially baited radial arm maze task in the presence and absence of restraint stress. Psychopharmacology (Berl) 193:363-374.
31. Sunanda, Shankaranarayana Rao BS, Raju TR (2000): Restraint stressinduced alterations in the levels of biogenic amines, amino acids, and AChE activity in the hippocampus. Neurochem Res 25:1547-1552.
32. Vandenbogaerde A, Zanoli P, Puia G, Truzzi C, Kamuhabwa A, De Witte P, Merlevede W, Baraldi M (2000): Evidence that total extract of hypericum perforatum affects exploratory behavior and exerts anxiolytic effect in rats. Pharmacol Biochem Behav 65:627-633.
33. Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S (2002): Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 22:6810-6818.
34. Weiner MF, Svetlik D, Risser RC (1997): What depressive symptoms are reported in Alzheimer's patients? Int J Geriatr Psychiatry 12:648-652.